Glaxo to share malaria drug data

Pharmaceutical giant GlaxoSmithKline (GSK) will release 13,500 malaria drug candidates into the public domain as part of its ‘open innovation’ agenda, it announced on 20 January 2010. Chief executive Andrew Witty outlined the company’s strategy for increasing its intellectual property flexibility and altering its business model to tackle neglected tropical diseases. “We’re trying to identify […]

Read More Glaxo to share malaria drug data